News & Updates

Ustekinumab improves outcomes in UC patients

Treatment with ustekinumab can help patients with ulcerative colitis (UC) achieve clinical and endoscopic outcomes of importance after 12 months, results of a real-world study have shown.

Nirmatrelvir-ritonavir shows benefits in immunocompromised individuals with COVID-19

Effective antiviral therapy is crucial for achieving sustained viral clearance and improving outcomes in patients with COVID-19, particularly among immunocompromised individuals.

At the recent ESCMID Global 2025 in Vienna, Austria, Ruth Mokgokong, a pharmacologist at Pfizer, UK, presented findings from the EPIC-IC trial, highlighting the benefits of an extended nirmatrelvir-ritonavir regimen in severely immunocompromised patients with symptomatic COVID-19.

Tirzepatide improves cardiometabolic markers in Chinese adults

Early weight loss associated with the use of tirzepatide may significantly improve cardiometabolic health, particularly in adults achieving a normal BMI by week 52, according to a China study.

Cannabis use doubles the risk of dying from heart disease

Cannabis use increases the risk of major adverse cardiovascular events (MACE), as shown in a robust meta-analysis, raising serious questions about the assumptions that cannabis use poses little cardiovascular (CV) risk among users.

Oral, transdermal hormone therapies equally preserve bone health in premature ovarian insufficiency

Hormone therapy, whether administered orally or applied transdermally, helps maintain bone mineral density in women with premature ovarian insufficiency, according to a single-centre retrospective study.

Point-of-care testing detects RTIs faster than ever

Respiratory tract infections (RTIs) have been on the rise post-COVID-19 pandemic.

Due to high patient volumes, delayed clinic presentations, and prolonged lead times for PCR testing in the laboratory, doctors need a rapid and accurate diagnostic tool to help improve in-clinic patient workflow.

CYP2C19 tied to voriconazole-related adverse reactions in kids

Carriers of the CYP2C19 allele are at greater risk of voriconazole-induced thrombocytopenia and cholestasis, reports a Japan study.